Clinical Trials Browser

Phase 2 × Neoplasms, Second Primary × Temozolomide × Clear all

NCT00638963 2017-06-14

STOP

Phase 2 Terminated

6 enrolled 9 charts

Brain Neoplasms, Breast Neoplasms, Neoplasms, Second Primary